Brief: Neubase Therapeutics Says Carnegie Mellon University Terminated License Agreement
22/12/2023 11:30
Dec 22 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS INC - CARNEGIE MELLON UNIVERSITY
TERMINATED
LICENSE AGREEMENT
* NEUBASE THERAPEUTICS INC - DID NOT INCUR ANY EARLY
TERMINATION
PENALTIES IN CONNECTION WITH THE TERMINATION OF THE LICENSE
AGREEMENT
* NEUBASE THERAPEUTICS INC - CMU TERMINATED LICENSE
AGREEMENT IN
CONNECTION WITH EXCLUSIVE, WORLDWIDE RIGHT TO PATROL TECHNOLOGY
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet